Sign Up Today and Learn More About Deep Genomics Stock
Invest in or calculate the value of your shares in Deep Genomics or other pre-IPO companies through EquityZen's platform.
Deep Genomics Stock (DEGE)
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.
About Deep Genomics Stock
Founded
2014
Total Funding
16.7M
Industries
Software, Artificial Intelligence, Data and Analytics
Deep Genomics Press Mentions
Stay in the know about the latest news on Deep Genomics
Systems and methods for predicting post transcriptional gene regulation using …
patents • Mar 01, 2026
Systems and methods for determining effects of therapies and genetic variation …
patents • Mar 01, 2026
5th Annual BioTech Breakthrough Awards Program Honors World’s Most Innovative Life Sciences and Biotechnology Companies
globenewswire • Nov 08, 2025
Thong Q. Le and Paul Sekhri Join Board of Directors at Deep Genomics
pharmiweb • Oct 15, 2025
Machine Learning in Pharmaceutical Industry Market Reach USD 26.2 Billion by 2031 Globally
einpresswire • Jun 25, 2025
Deep Genomics Management
Leadership team at Deep Genomics
Co-Founder
Hannes Bretschneider
Research Scientist & Engineer
Alice Gao
Join now and verify your accreditation status to gain access to:
- Deep Genomics Current Valuation
- Deep Genomics Stock Price
- Deep Genomics Management
- Available deals in Deep Genomics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Deep Genomics Cap Table and Funding History by Share Class and Liquidity Preferences
- Deep Genomics Revenue and Financials
- Deep Genomics Highlights
- Deep Genomics Business Model
- Deep Genomics Risk Factors
- Deep Genomics Research Report from SACRA Research
Trading Deep Genomics Stock
How to invest in Deep Genomics stock?
Accredited investors can buy pre-IPO stock in companies like Deep Genomics through EquityZen funds. These investments are made available by existing Deep Genomics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Deep Genomics stock?
Shareholders can sell their Deep Genomics stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
